Respiro Diagnostics

Respiro DiagnosticsRespiro Diagnostics
RD

Respiro Diagnostics

Developing breath-based diagnostics for lung diseases.

Website
ActiveCambridge, United Kingdom
Rate
Advertise here

About

Respiro Diagnostics is a UK-based startup developing a non-invasive liquid biopsy platform that uses exhaled breath to detect lung cancer and other respiratory diseases. Their technology combines a proprietary breath collection device with laboratory methods that analyze DNA, RNA, and proteins captured from breath samples, offering an alternative to invasive tissue biopsies and blood-based liquid biopsies. The platform aims to support earlier diagnosis and provide additional information to guide treatment decisions.

Technology stack

detected 2026-07-08
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Respiro Diagnostics do?

Respiro Diagnostics is a UK-based startup developing a non-invasive liquid biopsy platform that uses exhaled breath to detect lung cancer and other respiratory diseases. Their technology combines a proprietary breath collection device with laboratory methods that analyze DNA, RNA, and proteins captured from breath samples, offering an alternative to invasive tissue biopsies and blood-based liquid biopsies. The platform aims to support earlier diagnosis and provide additional information to guide…

How much funding has Respiro Diagnostics raised?

Respiro Diagnostics has raised a total of $1M in funding. The most recent round on record is Pre-Seed.

Where is Respiro Diagnostics headquartered?

Respiro Diagnostics is headquartered in Cambridge, United Kingdom.

What industry does Respiro Diagnostics operate in?

Respiro Diagnostics operates in Biotechnology, Healthcare, Diagnostics, Medical Devices, HealthTech, MedTech.

What is Respiro Diagnostics's revenue?

StartupHub estimates Respiro Diagnostics's annual revenue at $126K (range $33K to $420K, 37% confidence), based on comparable companies in the sector.

What is Respiro Diagnostics's valuation?

StartupHub estimates Respiro Diagnostics's effective valuation at $4.0M (range $2.5M to $6.0M, 25% confidence), based on comparable companies in the sector.